Cold Indication For Antihistamine Monograph Expected This Year – DNDP Director Michele
This article was originally published in The Tan Sheet & The Rose Sheet
Executive Summary
FDA this year will publish an antihistamine monograph rule stemming from a partnership with Canada, says Theresa Michele, director of the Division of Nonprescription Drug Products. At a recent CHPA conference, Michele suggested FDA will parlay strong momentum and internal improvements from 2015 into 2016 progress.
You may also be interested in...
Industry Groups Need FDA Input On Antibacterial Ingredient Studies
The Personal Care Products Council and American Cleaning Institute say industry needs FDA input on study designs and more time to study benzethonium and benzalkonium chloride in consumer antimicrobial wash products. FDA’s commitment under a 2013 consent decree to publish a monograph for triclosan use by September 2016 should not influence the GRASE status of other ingredients, the groups say.
Consent Decree Orders FDA Action On Triclosan OTC Monographs
A Nov. 21 consent decree sets multiple deadlines over a five-year period to make FDA finalize its OTC topical antimicrobial drug products monograph with respect to triclosan. Under one deadline of note to triclosan product makers, the agency must publish a tentative final monograph for consumer antiseptic hand wash products by Dec. 16, with a final monograph due by Sept. 15, 2016.
MoCRA Stakeholders Reminded Registration Enforcement Begins 1 July: ‘Do Not Delay!’
The Independent Beauty Association urged stakeholders at its Cosmetic Convergence Symposium to take action to ensure they are meeting requirements of the Modernization of Cosmetics Regulation Act come 1 July, when FDA’s enforcement of the facility and product registration deadline begins. Presenters offered tips from companies that have already completed the process.